A Pilot Randomized Trial of Transdermal Nicotine for Pulmonary Sarcoidosis.
Sign Up to like & getrecommendations! Published in 2021 at "Chest"
DOI: 10.1016/j.chest.2021.05.031
Abstract: BACKGROUND Tobacco smoking is associated with a reduced risk of developing sarcoidosis, and we previously reported that nicotine normalizes immune responses to environmental antigens in patients with active pulmonary sarcoidosis. The effects of nicotine on… read more here.
Keywords: trial; treatment; nicotine pulmonary; sarcoidosis ... See more keywords